Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hitomi Koizumi"'
Publikováno v:
Journal of Japan Academy of Midwifery; Apr2024, Vol. 38 Issue 1, p81-91, 11p
Autor:
Seiji Yano, Toshimitsu Uenaka, Takayuki Nakagawa, Saburo Sone, Yasuhiko Nishioka, Naofumi Mukaida, Kunio Matsumoto, Takahiro Nakamura, Hitomi Koizumi, Tadaaki Yamada, Shinji Takeuchi, Qi Li, Wei Wang
Purpose: Hepatocyte growth factor (HGF) induces resistance to reversible and irreversible epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer cells by activating Met and the downstream phosphoinositide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79aa4e296ff040d9e7c833b855bd7fb3
https://doi.org/10.1158/1078-0432.c.6521184.v1
https://doi.org/10.1158/1078-0432.c.6521184.v1
Autor:
Yuriko Kusumi, Hitomi Koizumi
Publikováno v:
International Journal of Nursing and Midwifery. 12:1-6
This study seeks to clarify the current situation and associated factors regarding Work Engagement (WE) among midwives working in advanced care facilities, which bear the brunt of care for high-risk pregnancies, as well as the contribution of WE to q
Publikováno v:
An Official Journal of the Japan Primary Care Association. 40:2-8
Publikováno v:
General Medicine. 15:34-42
Autor:
Takayuki Nakagawa, Hitomi Koizumi, Tadaaki Yamada, Takahiro Nakamura, Shinji Takeuchi, Seiji Yano, Kunio Matsumoto, Tetsuya Mitsudomi, Kenji Kita, Kenichi Suda
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 7(7)
Introduction: The three major clinically relevant mechanisms of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant lung cancer are a second mutation in the EGFR gene (T790M), Met amplificat
Autor:
Wei Wang, Toshimitsu Uenaka, Takayuki Nakagawa, Naofumi Mukaida, Shinji Takeuchi, Kunio Matsumoto, Hitomi Koizumi, Seiji Yano, Qi Li, Yasuhiko Nishioka, Tadaaki Yamada, Saburo Sone, Takahiro Nakamura
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 18(6)
Purpose: Hepatocyte growth factor (HGF) induces resistance to reversible and irreversible epidermal growth factor receptor–tyrosine kinase inhibitors (EGFR-TKI) in EGFR mutant lung cancer cells by activating Met and the downstream phosphoinositide
Publikováno v:
Japanese Journal of Oral & Maxillofacial Surgery. 45:354-356
Recently, actinomycosis has become a relatively rare bacterial infection, which is difficult to diagnose when clinical symptoms are not typical. We report a rare case of actinomycosis arising in the maxilla that showed atypical symptoms and was suspe
Publikováno v:
Cancer Research. 72:1907-1907
The three major, clinically relevant mechanisms of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR mutant lung cancer are a second mutation in the EGFR gene (T790M), Met amplification, and incr